Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
532.6 INR | +0.95% | -8.04% | +47.49% |
04-08 | Solara Active Pharma Sciences Limited Approves Appointment of Mohan Muthunarayanan as an Executive Director | CI |
03-26 | Solara Active Pharma Gets Board Nod to Sell 100% Stake in SeQuent Penems | MT |
Chart calendar Solara Active Pharma Sciences Limited
Upcoming events on Solara Active Pharma Sciences Limited
Past events on Solara Active Pharma Sciences Limited
14/02/2024 09:30 | Q3 2024 Earnings Call |
14/02/2024 08:33 | Q3 2024 Earnings Release |
14/11/2023 10:00 | Q2 2024 Earnings Call |
14/11/2023 09:33 | Q2 2024 Earnings Release |
15/09/2023 05:00 | Annual General Meeting |
14/08/2023 11:00 | Q1 2024 Earnings Call |
14/08/2023 09:30 | Q1 2024 Earnings Release |
12/05/2023 11:00 | Q4 2023 Earnings Call |
12/05/2023 10:02 | Q4 2023 Earnings Release |
25/01/2023 10:00 | Q3 2023 Earnings Call |
24/01/2023 | Q3 2023 Earnings Release |
09/11/2022 10:30 | Interim 2023 Earnings Call |
09/11/2022 07:55 | Interim 2023 Earnings Release |
25/08/2022 05:00 | Annual General Meeting |
04/08/2022 11:30 | Q1 2023 Earnings Call |
04/08/2022 09:20 | Q1 2023 Earnings Release |
29/04/2022 11:00 | FY 2022 Earnings Call |
29/04/2022 10:36 | FY 2022 Earnings Release |
09/02/2022 10:37 | Q3 2022 Earnings Release |
09/02/2022 10:30 | Q3 2022 Earnings Call |
Past dividends on Solara Active Pharma Sciences Limited
17/08/2021 | Final Payment 3 INR |
18/11/2020 | Interim Payment 4 INR |
27/07/2020 | Annual 2 INR |
05/08/2019 | Annual 5 INR |
Annual results
Fiscal Period | Marzo | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 13 218 13 996 -5.56% | 16 169 16 561 -2.37% | 12 683 14 963 -15.23% | 14 438 14 687 -1.69% | 14 308 |
EBITDA Million INR | Released Forecast Spread | 2 870 3 077 -6.73% | 3 859 3 914 -1.41% | 800 1 734 -53.88% | 1 565 1 353 15.61% | 460 |
EBIT Million INR | Released Forecast Spread | 0,00 0,00 - | 2 772 2 893 -4.17% | -324 156 -307.37% | 453 279 62.26% | -1 569 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 1 149 1 352 -14.99% | 2 215 2 266 -2.23% | -911 5,33 -17181.26% | -448 -429 -4.53% | -3 211 |
Net income Million INR | Released Forecast Spread | 1 146 1 328 -13.72% | 2 214 2 266 -2.29% | -582 6,00 -9791.67% | -222 -331 33.09% | -3 211 |
EPS INR | Released Forecast Spread | 42,8 51,0 -16.06% | 64,5 63,6 1.53% | -16,2 2,75 -688.36% | -6,16 -9,20 33.04% | 0,00 |
Announcement Date | 07/05/20 | 06/05/21 | 29/04/22 | 12/05/23 | - |
Quarterly results
Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 4 442 5 139 -13.56% | 4 056 4 903 -17.29% | 4 016 4 339 -7.44% | 1 003 3 999 -74.91% | 3 608 3 432 5.14% | 3 301 3 719 -11.26% | 3 384 3 526 -4.04% | 3 948 3 698 6.76% | 3 806 4 056 -6.16% | 3 523 4 038 -12.75% | 3 835 | 4 362 | 4 035 |
EBITDA Million INR | Released Forecast Spread | 991 1 052 -5.79% | 908 1 186 -23.41% | 719 982 -26.82% | -968 693 -239.81% | 135 352 -61.56% | 126 245 -48.85% | 276 308 -10.58% | 450 376 19.68% | 475 476 -0.13% | 191 547 -65.05% | 332 | 419 | 448 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 501 915 -45.23% | 297 448 -33.75% | -1 399 268 -621.98% | -310 -260 -19.23% | -311 -249 -24.9% | -193 -189 -2.12% | 5,50 -76,0 107.24% | 50,4 23,0 119.13% | -294 124 -336.77% | -172 | -33,0 | -14,0 | |
Net income Million INR | Released Forecast Spread | 501 759 -33.91% | 297 492 -39.55% | -1 399 268 -621.9% | 18,8 -260 107.23% | -164 -249 34.02% | -99,6 -83,5 -19.28% | 4,50 -60,0 107.5% | 37,7 25,0 50.8% | -196 80,7 -342.36% | -126 | -32,0 | 11,0 | |
Announcement Date | 06/05/21 | 04/08/21 | 11/11/21 | 09/02/22 | 29/04/22 | 04/08/22 | 09/11/22 | 25/01/23 | 12/05/23 | 14/08/23 | - | - | - |
Today 07:00 | GSK PLC: Q1 2024 Earnings Release |
Today 08:00 | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
Today 11:45 | PFIZER, INC.: Q1 2024 Earnings Release |
Today 21:05 | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
Today 21:05 | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
01/05/2024 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
01/05/2024 | AMGEN INC.: Q1 2024 Earnings Release |
02/05/2024 06:30 | NOVO NORDISK A/S: Q1 2024 Earnings Release |
02/05/2024 12:30 | ORGANON & CO.: Q1 2024 Earnings Release |
02/05/2024 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
Past sector events for Solara Active Pharma Sciences Limited
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SOLARA Stock
- Calendar Solara Active Pharma Sciences Limited